Advertisement

Journal of Molecular Neuroscience

, Volume 66, Issue 2, pp 261–272 | Cite as

Neuregulin-1β Plays a Neuroprotective Role by Inhibiting the Cdk5 Signaling Pathway after Cerebral Ischemia-Reperfusion Injury in Rats

  • Rui Zhang
  • Cui Liu
  • Yaqing Ji
  • Lei Teng
  • Yunliang Guo
Article
  • 78 Downloads

Abstract

This study investigated the effects of neuregulin-1β (NRG1β) after middle cerebral artery occlusion/reperfusion (MCAO/R) in rats to evaluate whether they occur via the cyclin-dependent kinase (Cdk)5 signaling pathway. One hundred adult male Wistar rats were randomly divided into sham, MCAO/R, treatment (NRG1β), inhibitor (roscovitine; Ros), and inhibitor + treatment (Ros + NRG1β) groups. The MCAO/R model was established using the intraluminal thread method. The neurobehavioral function was evaluated by the modified neurological severity score (mNSS). The cerebral infarction volume (CIV) was measured by triphenyl tetrazolium chloride (TTC) staining. Morphological changes were observed by hematoxylin-eosin (HE) staining. The apoptotic cell index (ACI) was detected by the terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) assay. Immunohistochemistry and Western blotting were performed to detect the expression of calpain 1, p35/p25 (regulatory binding partners of Cdk5), Cdk5, and p-Tau in neurons. The neuronal morphology in the MCAO/R, NRG1β, Ros + NRG1β, and Ros groups differed compared to the sham group; the mNSS, CIV, ACI, and the expression of calpain 1, p35/p25, Cdk5, and p-Tau were significantly increased in all four groups (P < 0.05). In the NRG1β, Ros and Ros + NRG1β groups, the neuronal morphology was significantly improved compared to the MCAO/R group, as were the mNSS, CIV, and ACI. The levels of calpain 1, p35/p25, and p-Tau were decreased compared with the MCAO/R group (P < 0.05), while the Cdk5 expression was not significantly different (P > 0.05). NRG1β may exert neuroprotective effects by inhibiting the expression of calpain 1, p35/p25, and p-Tau after cerebral ischemia-reperfusion injury.

Keywords

Cerebral ischemia Reperfusion injury Cdk5 Neuregulin-1β Signaling pathway 

Notes

Funding Information

This work was supported by grants from the National Natural Science Foundation of China (81274116), the Taishan Scholars Construction Project Excellent Innovative Team of Shandong Province, and the Youth Fund Project of the Affiliated Hospital of Qingdao University. None of these organizations was involved in the design, performance, collection of data, analysis, interpretation, or presentation of this study.

Compliance with Ethical Standards

The National Institutes of Health Guide for the Care and Use of Laboratory Animals was used as a guide for the design of all animal-related studies. All animal-related experiments were performed using protocols approved by our institute (The Ethics Committee of Qingdao University Medical College, QUMC 2011-09).

Conflicts of Interest

The authors declare that they have no conflicts of interest.

References

  1. Bajaj NP (2000) Cyclin-dependent kinase-5 (CDK5) and amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:319–327CrossRefGoogle Scholar
  2. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M (2001) Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32:2682–2688CrossRefGoogle Scholar
  3. Chen X, Oh SW, Zheng Z, Chen HW, Shin HH, Hou SX (2003) Cyclin D-Cdk4 and cyclin E-Cdk2 regulate the Jak/STAT signal transduction pathway in Drosophila. Dev Cell 4:179–190CrossRefGoogle Scholar
  4. Chen Y, Zhang MZ, Li Q, Guo YL, Ding W, Wang LH, Zhou Z, Chen XP (2011) Interfering effect and mechanism of neuregulin on experimental dementia models in rats. Behav Brain Res 222:321–325.  https://doi.org/10.1016/j.bbr.2011.03.063 CrossRefPubMedGoogle Scholar
  5. Curcio M, Salazar IL, Mele M, Canzoniero LM, Duarte CB (2016) Calpains and neuronal damage in the ischemic brain: the swiss knife in synaptic injury. Prog Neurobiol 143:1–35.  https://doi.org/10.1016/j.pneurobio.2016.06.001. CrossRefPubMedGoogle Scholar
  6. Czapski GA, Gąssowska M, Songin M, Radecka UD, Strosznajder JB (2011) Alterations of cyclin dependent kinase 5 expression and phosphorylation in amyloid precursor protein (APP)-transfected PC12 cells. FEBS Lett 585:1243–1248.  https://doi.org/10.1016/j.febslet.2011.03.058 CrossRefPubMedGoogle Scholar
  7. du Bois TM, Newell KA, Huang XF (2012) Perinatal phencyclidine treatment alters neuregulin1/erbB4 expression and activation in later life. Eur Neuropsychopharmacol 22:356–363.  https://doi.org/10.1016/j.euroneuro.2011.09.002 CrossRefPubMedGoogle Scholar
  8. Fenster C, Vullhorst D, Buonanno A (2012) Acute neuregulin-1 signaling influences AMPA receptor mediated responses in cultured cerebellar granule neurons. Brain Res Bull 87:21–29.  https://doi.org/10.1016/j.brainresbull.2011.10.011 CrossRefPubMedGoogle Scholar
  9. Frade JM (2000) Unscheduled re-entry into the cell cycle induced by NGF precedes cell death in nascent retinal neurons. J Cell Sci 113:1139–1148PubMedGoogle Scholar
  10. Fu AK, Fu WY, Cheung J, Tsim KW, Ip FC, Wang JH, Ip NY (2001) Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nat Neurosci 4:374–381.  https://doi.org/10.1038/86019 CrossRefPubMedGoogle Scholar
  11. Gui C, Zhu L, Hu M, Lei L, Long Q (2012) Neuregulin-1/ErbB signaling is impaired in the rat model of diabetic cardiomyopathy. Cardiovasc Pathol 21:414–420.  https://doi.org/10.1016/j.carpath.2011.12.006 CrossRefPubMedGoogle Scholar
  12. Guo YL, Gao HM, Li ZX, Liu XJ, Du F, Zhang R, Li Q, Wang T (2008) The evaluation of focal cerebral ischemic reperfusion model with middle cerebral artery occlusion by micro-balloon in rhesus monkeys. Acta Anatomica Sinica 39:944–947Google Scholar
  13. Hashiguchi M, Saito T, Hisanaga S, Hashiguchi T (2002) Truncation of CDK5 activator p35 induces intensive phosphorylation of Ser202/Thr205 of human tau. J Biol Chem 277:44525–44530.  https://doi.org/10.1074/jbc.M207426200 CrossRefPubMedGoogle Scholar
  14. Hayashi T, Warita H, Abe K, Itoyama Y (1999) Expression of cyclin-dependent kinase 5 and its activator p35 in rat brain after middle cerebral artery occlusion. Neurosci Lett 265:37–40CrossRefGoogle Scholar
  15. Heiss WD (2011) The ischemic penumbra: correlates in imaging and implications for treatment of ischemic stroke. The Johann Jacob Wepfer award 2011. Cerebrovasc Dis 32:307–320.  https://doi.org/10.1159/000330462 CrossRefPubMedGoogle Scholar
  16. Hoffmann I, Bueter W, Zscheppang K, Brinkhaus MJ, Liese A, Riemke S, Dörk T, Dammann O, Dammann CE (2010) Neuregulin-1, the fetal endothelium, and brain damage in preterm newborns. Brain Behav Immun 24:784–791.  https://doi.org/10.1016/j.bbi.2009.08.012 CrossRefPubMedGoogle Scholar
  17. Huang YZ, Mei L (2001) Signal transduction of neuregulin/ErbB in the development of nervous system. Prog Physiol Sci 32:197–203Google Scholar
  18. Jaffer H, Morris VB, Stewart D, Labhasetwar V (2011) Advances in stroke therapy. Drug Deliv Transl Res 1:409–419.  https://doi.org/10.1007/s13346-011-0046-y CrossRefPubMedPubMedCentralGoogle Scholar
  19. Jessberger S, Gage FH, Eisch AJ, Lagace DC (2009) Making a neuron: Cdk5 in embryonic and adult neurogenesis. Trends Neurosci 32:575–582.  https://doi.org/10.1016/j.tins.2009.07.002 CrossRefPubMedPubMedCentralGoogle Scholar
  20. Ji YQ, Zhang R, Teng L, Li HY, Guo YL (2017) Study of neuron-protective effect and mechanism of neuregulin1β against cerebral ischemia reperfusion-induced injury in rats. Natl Med J China 97:2128–2134.  https://doi.org/10.3760/cma.j.issn.0376-2491.2017.27.011 CrossRefGoogle Scholar
  21. Kalathur RK, Hernández-Prieto MA, Futschik ME (2012) Huntington’s disease and its therapeutic target genes: a global functional profile based on the HD research crossroads database. BMC Neurol 12:36–47.  https://doi.org/10.1186/1471-2377-12-47 CrossRefGoogle Scholar
  22. Lai KO, Ip NY (2009) Recent advances in understanding the roles of Cdk5 in synaptic plasticity. Biochim Biophys Acta 1792:741–745.  https://doi.org/10.1016/j.bbadis.2009.05.001 CrossRefPubMedGoogle Scholar
  23. Li BS, Ma W, Jaffe H, Zheng Y, Takahashi S, Zhang L, Kulkarni AB, Pant HC (2003) Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival. J Biol Chem 278:35702–35709.  https://doi.org/10.1074/jbc.M302004200 CrossRefPubMedGoogle Scholar
  24. Li Y, Xu Z, Ford GD, Croslan DR, Cairobe T, Li Z, Ford BD (2007) Neuroprotection by neuregulin-1 in a rat model of permanent focal ischemia. Brain Res 1184:277–283.  https://doi.org/10.1016/j.brainres.2007.09.037 CrossRefPubMedPubMedCentralGoogle Scholar
  25. Li Q, Li Z, Mei Y, Guo Y (2008) Neuregulin attenuated cerebral ischemia-Creperfusion injury via inhibiting apoptosis and upregulating aquaporin-4. Neurosci Lett 443:155–159.  https://doi.org/10.1016/j.neulet.2008.07.064 CrossRefPubMedGoogle Scholar
  26. Li Q, Zhang R, Guo YL, Mei YW (2009a) Effect of neuregulin on apoptosis and expressions of STAT3 and GFAP in rats following cerebral ischemic reperfusion. J Mol Neurosci 37:67–73.  https://doi.org/10.1007/s12031-008-9121-3 CrossRefPubMedGoogle Scholar
  27. Li Q, Zhang R, Ge YL, Mei YW, Guo YL (2009b) Effects of neuregulin on expression of MMP-9 and NSE in brain of ischemia/reperfusion rat. J Mol Neurosci 38:207–215.  https://doi.org/10.1007/s12031-008-9150-y CrossRefPubMedGoogle Scholar
  28. Li Y, Lein PJ, Liu C, Bruun DA, Giulivi C, Ford GD, Tewolde T, Ross-Inta C, Ford BD (2012) Neuregulin-1 is neuroprotective in a rat model of organophosphate-induced delayed neuronal injury. Toxicol Appl Pharmacol 262:194–204.  https://doi.org/10.1016/j.taap.2012.05.001 CrossRefPubMedPubMedCentralGoogle Scholar
  29. Love S (2003) Neuronal expression of cell cycle-related proteins after brain ischaemia in man. Neurosci Lett 353:29–32CrossRefGoogle Scholar
  30. Menn B, Bach S, Blevins TL, Campbell M, Meijer L, Timsit S (2010) Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models. PLoS One 5:e12117.  https://doi.org/10.1371/journal.pone.0012117 CrossRefPubMedPubMedCentralGoogle Scholar
  31. Nagasawa H, Kogure K (1989) Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 20:1037–1043CrossRefGoogle Scholar
  32. Otth C, Mendoza-Naranjo A, Mujica L, Zambrano A, Concha II, Maccioni RB (2003) Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer’s disease. Neuroreport 14:2403–2409.  https://doi.org/10.1097/01.wnr.0000099988.54721.3c CrossRefPubMedGoogle Scholar
  33. Qu D, Rashidian J, Mount MP, Aleyasin H, Parsanejad M, Lira A, Haque E, Zhang Y, Callaghan S, Daigle M, Rousseaux MW, Slack RS, Albert PR, Vincent I, Woulfe JM, Park DS (2007) Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson’s disease. Neuron 55:37–52.  https://doi.org/10.1016/j.neuron.2007.05.033 CrossRefPubMedGoogle Scholar
  34. Rai A, Tripathi S, Kushwaha R, Singh P, Srivastava P, Sanyal S, Bandyopadhyay S (2014) CDK5-induced p-PPARγ(Ser 112) downregulates GFAP via PPREs in developing rat brain: effect of metal mixture and troglitazone in astrocytes. Cell Death Dis 5:e1033.  https://doi.org/10.1038/cddis.2013.514 CrossRefPubMedPubMedCentralGoogle Scholar
  35. Rashidian J, Rousseaux MW, Venderova K, Qu D, Callaghan SM, Phillips M, Bland RJ, During MJ, Mao Z, Slack RS, Park DS (2009) Essential role of cytoplasmic cdk5 and Prx2 in multiple ischemic injury models, in vivo. J Neurosci 29:12497–12505.  https://doi.org/10.1523/JNEUROSCI.3892-09.2009 CrossRefPubMedPubMedCentralGoogle Scholar
  36. Rui Z, Qin L, Wang T, Fang D, Guo YL (2009) Interfering effect of neuregulin upon cerebral ischemic reperfusion injury in rhesus monkeys. Natl Med J China 89:1361–1364Google Scholar
  37. Sallam H, Jimenez P, Song H, Vita M, Cedazo-Minguez A, Hassan M (2008) Age-dependent pharmacokinetics and effect of roscovitine on Cdk5 and Erk1/2 in the rat brain. Pharmacol Res 58:32–37.  https://doi.org/10.1016/j.phrs.2008.05.010 CrossRefPubMedGoogle Scholar
  38. Song F, Chiang P, Wang J, Ravits J, Loeb JA (2012) Aberrant neuregulin 1 signaling in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 71:104–115.  https://doi.org/10.1097/NEN.0b013e3182423c43 CrossRefPubMedPubMedCentralGoogle Scholar
  39. Tan X, Chen Y, Li J, Li X, Miao Z, Xin N, Zhu J, Ge W, Feng Y, Xu X (2015) The inhibition of Cdk5 activity after hypoxia/ischemia injury reduces infarct size and promotes functional recovery in neonatal rats. Neurosci 290:552–560.  https://doi.org/10.1016/j.neuroscience.2015.01.054 CrossRefGoogle Scholar
  40. Timsit S, Menn B (2012) Cyclin-dependent kinase inhibition with roscovitine: neuroprotection in acute ischemic stroke. Clin Pharmacol Ther 91:327–332.  https://doi.org/10.1038/clpt.2011.312 CrossRefPubMedGoogle Scholar
  41. Woo RS, Lee JH, Kim HS, Baek CH, Song DY, Suh YH, Baik TK (2012) Neuregulin-1 protects against neurotoxicities induced by Swedish amyloid precursor protein via the Erbb4 receptor. Neurosci 202:413–423.  https://doi.org/10.1016/j.neuroscience.2011.11.026 CrossRefGoogle Scholar
  42. Xu ZF, Ford BD (2005) Upregulation of erbB receptors in rat brain after middle cerebral arterial occlusion. Neurosci Lett 375:181–186.  https://doi.org/10.1016/j.neulet.2004.11.039 CrossRefPubMedGoogle Scholar
  43. Xu Z, Ford GD, Croslan DR, Jiang J, Gates A, Allen R, Ford BD (2005) Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression. Neurobiol Dis 19:461–470.  https://doi.org/10.1016/j.nbd.2005.01.027 CrossRefPubMedGoogle Scholar
  44. Yue W, Song L, Fu G, Li Y, Liu H (2013) Neuregulin-1β regulates tyrosine kinase receptor expression in cultured dorsal root ganglion neurons with excitotoxicity induced by glutamate. Regul Pept 180:33–42.  https://doi.org/10.1016/j.regpep.2012.10.005 CrossRefPubMedGoogle Scholar
  45. Zhang J, Cicero SA, Wang L, Romito-Digiacomo RR, Yang Y, Herrup K (2008) Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons. Proc Natl Acad Sci U S A 105:8772–8777.  https://doi.org/10.1073/pnas.0711355105 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of ICUAffiliated Hospital of Qingdao UniversityQingdaoChina
  2. 2.Department Traumic SurgeryAffiliated Hospital of Qingdao UniversityQingdaoChina
  3. 3.Institute of Integrative MedicineAffiliated Hospital of Qingdao UniversityQingdaoChina
  4. 4.Department of BiologyAffiliated Hospital of Qingdao UniversityQingdaoChina
  5. 5.Institute of Cerebrovascular Diseases, Affiliated Hospital of Qingdao UniversityShandong Provincial Collaborative Innovation Center for Neurodegenerative DisordersQingdaoChina

Personalised recommendations